BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32161126)

  • 1. CD29 identifies IFN-γ-producing human CD8
    Nicolet BP; Guislain A; van Alphen FPJ; Gomez-Eerland R; Schumacher TNM; van den Biggelaar M; Wolkers MC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6686-6696. PubMed ID: 32161126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD29 Enriches for Cytotoxic Human CD4
    Nicolet BP; Guislain A; Wolkers MC
    J Immunol; 2021 Dec; 207(12):2966-2975. PubMed ID: 34782446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.
    Morisaki T; Morton DL; Uchiyama A; Yuzuki D; Barth A; Hoon DS
    Cancer Immunol Immunother; 1994 Sep; 39(3):172-8. PubMed ID: 7923247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
    Sandberg JK; Fast NM; Nixon DF
    J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
    Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
    Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans.
    Wang A; Chandran S; Shah SA; Chiu Y; Paria BC; Aghamolla T; Alvarez-Downing MM; Lee CC; Singh S; Li T; Dudley ME; Restifo NP; Rosenberg SA; Kammula US
    Sci Transl Med; 2012 Aug; 4(149):149ra120. PubMed ID: 22932225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
    Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
    Wang Y; Da'Dara AA; Thomas PG; Harn DA
    Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
    Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iCa
    Mohanty S; Barik P; Debata N; Nagarajan P; Devadas S
    Front Immunol; 2020; 11():83. PubMed ID: 32210950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.
    Tau GZ; Cowan SN; Weisburg J; Braunstein NS; Rothman PB
    J Immunol; 2001 Nov; 167(10):5574-82. PubMed ID: 11698428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
    Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
    Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.